Scarica l'app Stockscreener
27.65
0.47%
-0.13
Dopo l'orario di chiusura:
27.67
0.02
+0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer (PFE) Exits Legacy Hypertension Brands In India - simplywall.st
Why Pfizer (NYSE:PFE) Is Standing Out As Defensive Healthcare Draws Notice - Kalkine Media
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot - Yahoo Finance
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? - Trefis
Medicus Pharma secures Pfizer ADC deal, advances SkinJect and precision oncology strategy - Proactive financial news
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff - Zacks Investment Research
NVAX: Sanofi and Pfizer deals fuel pipeline expansion, milestone payments, and global vaccine market growth - TradingView
Pfizer Stock: Firing On All Cylinders (NYSE:PFE) - Seeking Alpha
Pfizer Inc. stock steadies as analysts lift targets and 2026 guidance firms - ad-hoc-news.de
Novartis India zooms 51% in 3 days; what's driving the pharma stock? - Business Standard
Pfizer stock heads into the open after a 2.3% slide - ad-hoc-news.de
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks - Yahoo Finance
Pfizer Inc. stock slips as BMO Capital keeps positive stance and options activity spikes - ad-hoc-news.de
Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3% - BusinessLine
Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit? - Yahoo Finance
Novartis India to Acquire Pfizer’s BP Drug Brands for ₹1,250 Crore - Chemical Industry Digest
Mandi Rollerson Takes on New AI Change and Adoption Leadership Role at Pfizer - hrtoday.in
Why Pfizer Stock Was so Healthy in August - Yahoo Finance
Inside Pfizer’s Fight Against Counterfeit Medicine - Pfizer
Pfizer Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
PFE Stock Quote Price and Forecast - CNN
Why Is Pfizer (NYSE:PFE) Trading At Such A Wide Discount To Its Healthcare Peers? - Kalkine Media
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ConferenceSeptember 8, 2026 - BioSpace
💊 Pfizer to discontinue Minipress XL in India 🤝 Novartis India buys the brand for ₹1,250 crore 📉 But Pfizer India gets just ₹131 crore of the deal Ekta Batra #Pfizer #Novartis #MinipressXL #PfizerIndia #NovartisIndia #CNBCTV18Digital - linkedin.com
Precision Trading with Pfizer Inc. (PFE) Risk Zones - Stock Traders Daily
Novartis India acquires Pfizer brands for $132m - Yahoo Finance
Pfizer shares hit 52-week low after Minipress XL discontinuation; Novartis zooms 13% - Business Today
Novartis India to Acquire Minipress, Minipres Trademarks From Pfizer for Rs 1,250 Crore - Medical Dialogues
Pfizer to Discontinue Minipress XL in India, Receives USD 13.9 Mn From US Parent - Medical Dialogues
Pfizer stock heads into the open after a flat close - ad-hoc-news.de
Pfizer (PFE) Hands Broad Rights On CD228V In New Oncology Licensing Deal - simplywall.st
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now - Yahoo Finance
Maharashtra: Novartis India buys Minipress brands from Pfizer for Rs 1250 crore - deccanchronicle.com
This Is What I'd Do With Pfizer Stock Right Now - The Globe and Mail
Novartis India to Acquire Pfizer’s Minipress Trademarks for Rs 1,250 Crore - ChemAnalyst
Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for ₹1,250 crore - BusinessLine
ChrysCap-controlled Novartis India to buy Pfizer’s blood pressure brand Minipress - VCCircle
Novartis India buys Minipress brands from Pfizer for ₹1,250 crore - Business Standard
Novartis India to acquire Pfizer's 'Minipress' trademark for ₹1,250 crore - ET Manufacturing
Novartis India to Buy Pfizer’s Minipress Brand for Rs 1,250 Cr - Equitypandit
Pfizer Inc. stock gains on Minipress XL exit and solid Q2 2026 figures - ad-hoc-news.de
Novartis India to acquire Minipress, Minipres Trademarks from Pfizer for Rs 1,250 crore - Business Upturn
Novartis India: Why Is the Pharma Stock Spending ₹1,250 Crore to Acquire Pfizer’s Minipress Brand? - Trade Brains
Pfizer, Inc. (PFE) Stock Analysis: Evaluating the 6.05% Dividend Yield and Its Implications for Investors - DirectorsTalk Interviews
Novartis India Expands Portfolio With INR 1,250 Crore Acquisition of Pfizer's Minipress Trademarks - latestly.com
Pfizer to Receive Rs 131.38 Crore After Minipress XL Discontinuation; Know Details - Dalal Street Investment Journal
Novartis India to acquire Pfizer trademarks 'Minipress' and 'Minipres' for Rs 1,250 crore - Mid-Day
Novartis India buys Minipress, Minipres rights from Pfizer for ₹1,250cr - NewsBytes
Novartis India Buys Minipress From Pfizer For ₹1,250 Crore - Whalesbook
Minipress changes hands: Novartis India buys Pfizer brands for Rs 1,250 crore - Moneycontrol.com
Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore - The Economic Times
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore - BusinessLine
Pfizer to cease Minipress XL operations, secures USD 13.9 million from US parent - Business Upturn
Novartis India Acquires Pfizer's Minipress for ₹1,250 Cr - Rediff MoneyWiz
Novartis India shares jump 4% on Rs 1,250 crore Pfizer trademarks acquisition - Business Today
Novartis India Buys Minipress Brand For ₹1,250 Crore, Pfizer To Stop Selling Hypertension Drug - Free Press Journal
Pfizer to Discontinue Minipress XL, Receives $13.9M - InvestyWise
Novartis India to acquire Minipress, Pfizer’s high blood pressure drug, for ₹1,250 crore - CNBC TV18
News by CNBC TV18 on TradingView, 2026-09-07 — cnbctv:e8e1f8f6f094b:0 - TradingView
0.58%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):